Rapid Escalation Oral Immunotherapy to Achieve Remission in Children With Cashew Allergy

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
Children with cashew allergy have no approved treatment and must rely on lifelong avoidance, which is stressful and often fails. Less than 10% outgrow their allergy. Cashew is a leading cause of severe reactions in young children. Oral immunotherapy (OIT) can induce remission in peanut allergy, allowing children to eat peanut safely, but this has not been tested for cashew. This study will assess whether cashew OIT can safely achieve remission and improve quality of life.
Epistemonikos ID: 5eed945bdec82979f6e8621cedd544f2707886f0
First added on: Oct 10, 2026